Hillview Capital Advisors, LLC - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 40 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Hillview Capital Advisors, LLC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q2 2019$23,000
-39.5%
19,6100.0%0.12%
-39.1%
Q1 2019$38,000
-15.6%
19,6100.0%0.20%
-25.5%
Q4 2018$45,000
-66.4%
19,6100.0%0.27%
-47.7%
Q3 2018$134,000–19,610–0.52%–
 Download
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q1 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,336,248$1,550,0001.95%
Hillview Capital Advisors, LLC 19,610$23,0000.12%
GSA CAPITAL PARTNERS LLP 64,786$75,0000.01%
Virtu Financial LLC 62,822$73,0000.00%
BREWIN DOLPHIN LTD 25,000$29,0000.00%
Paloma Partners Management Co 89,694$104,0000.00%
JANE STREET GROUP, LLC 12,923$15,0000.00%
UBS Group AG 61$00.00%
BARCLAYS PLC 240$00.00%
SIMPLEX TRADING, LLC 337$00.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders